Research Report: Accelerating Adoption of Monitoring, In Vitro Diagnostic Devices, Will Expand mHealth | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Research Report: Accelerating Adoption of Monitoring, In Vitro Diagnostic Devices, Will Expand mHealth

July 2, 2014
by Mark Hagland
| Reprints
The accelerating adoption of vital-signs monitoring and in vitro diagnostic devices will cause the mHealth market to grow eight-fold from 2013 to 2023, according to a new report from Lux Research

The accelerating adoption of vital-signs monitoring and in vitro diagnostic (IVD) devices will help to expand the mobile health (mHealth) market, causing it to grow eight-fold from $5.1 billion in 2013 to $41.8 billion in 2023, according to a new report from the Boston-based Lux Research Inc.

According to the report, “Clinical mHealth devices will soar past consumer-focused counter-focused counterparts after a slow start due to regulatory approval barriers and slower integration into physicians’ workflows. For instance,” the July 1 press release on the report notes, “clinical vital signs monitoring devices will grow from $372 million in 2013 to $16 billion in 2023, a compound annual growth rate of 46 percent, while consumer applications will grow from $2.5 billion to $7 billion an 11 percent CAGR.”

The release quotes Nick Kurkjy, a Lux Research associate and lead author of the report, as saying, “Consumer devices have seen a lot of hype but clinical devices will surpass their consumer counterparts in revenues by 2020, helped by value-added software services and generally larger revenue streams.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).